Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.

Impact of Advances in Anion Exchange Membranes and Ionomers on Alkaline Fuel Cells.

Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial.

Transcriptional Elongation-Associated RNA Processing Errors in Induced Cellular Growth Arrest.

Prediction of Mortality After Convulsive Status Epilepticus: The Status Epilepticus M(3)A(2)S(2)H Score.

Acquired resistance to immune checkpoint therapy is caused by glycoprotein non-metastatic melanoma protein B signal cascade.

Aging activates escape of the silent X chromosome in the female mouse hippocampus.

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.

Genomic insights into plasmid mediated AMR genes, virulence factors and mobile genetic elements in raw milk Escherichia coli from Gujarat, India.

Achieving universal health coverage in India: a scoping review on the requisite public health actions.

Relating DNA sequence, organization, and function.

The PRC2.1 subcomplex opposes G1 progression through regulation of CCND1 and CCND2.

Beyond genomic weaving: molecular roles for CTCF outside cohesin loop extrusion.

Recommended Practices for the Electrochemical Recovery of Cobalt from Lithium Cobalt Oxide: A Case Study of the Choline Chloride:Ethylene Glycol Deep Eutectic Solvent.

An Open-Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second-Line Therapy for Advanced Head and Neck Squamous Cell Cancers.